Home LiteratureArticle Details
PMID: 16897723 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.

Hippocampus ·Vol. 16 ·No. 10 ·2006-00-00 ·Pages 834-42

Karanian DA, Baude AS, Brown QB, Parsons CG, Bahr BA

Abstract

The over-activation of glutamate receptors can lead to excitotoxic cell death and is believed to be involved in the progression of neurodegenerative events in the vulnerable hippocampus. Here, we used an in vitro slice model to study toxicity produced in the hippocampus by the mitochondrial toxin 3-nitropropionic acid (3-NP). The organotypic slice cultures exhibit native cellular organization as well as dense arborization of neuronal processes and synaptic contacts. The hippocampal slices were exposed to 3-NP for 2-20 days, causing calpain-mediated breakdown of the spectrin cytoskeleton, a loss of pre- and postsynaptic markers, and neuronal atrophy. The N-methyl-D-aspartate (NMDA) receptor antagonist memantine reduced both the cytoskeletal damage and synaptic decline in a dose-dependent manner. 3-NP-induced cytotoxicity, as determined by the release of lactate dehydrogenase, was also reduced by memantine with EC50 values from 1.7 to 2.3 microM. Propidium iodide fluorescence and phase contrast microscopy confirmed memantine neuroprotection against the chronic toxin exposure. In addition, the protected tissue exhibited normal neuronal morphology in the major hippocampal subfields. These results indicate that antagonists of NMDA-type glutamate receptors are protective during the toxic outcome associated with mitochondrial dysfunction. They also provide further evidence of memantine's therapeutic potential against neurodegenerative diseases.

MeSH Terms
Animals Animals, Newborn Cytoskeleton/drug effects,pathology Dose-Response Relationship, Drug Excitatory Amino Acid Antagonists/pharmacology,therapeutic use Glutamic Acid/metabolism Hippocampus/drug effects,metabolism,physiopathology Memantine/pharmacology Mitochondria/drug effects,metabolism Nerve Degeneration/chemically induced,drug therapy,prevention & control Neural Pathways/drug effects,metabolism,physiopathology Neurodegenerative Diseases/drug therapy,metabolism,physiopathology Neurons/drug effects,metabolism,pathology Neuroprotective Agents/pharmacology,therapeutic use Neurotoxins/antagonists & inhibitors,toxicity Nitro Compounds/antagonists & inhibitors,toxicity Organ Culture Techniques Propionates/antagonists & inhibitors,toxicity Rats Rats, Sprague-Dawley Receptors, N-Methyl-D-Aspartate/drug effects,metabolism Synapses/drug effects,metabolism,pathology Synaptic Transmission/drug effects,physiology
Chemicals
Excitatory Amino Acid Antagonists Neuroprotective Agents Neurotoxins Nitro Compounds Propionates Receptors, N-Methyl-D-Aspartate Glutamic Acid 3-nitropropionic acid Memantine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Karanian David A
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269-3092, USA. david.karanian@uconn.edu
Baude Andrea S
Brown Queenie B
Parsons Christopher G
Bahr Ben A
Article Info
Journal
Hippocampus
Abbr.
Hippocampus
ISSN
1050-9631
Published
2006-00-00
Pages
834-42
Language
English
Region
United States
NLM ID
9108167
Subset
IM
Grants
NIDA NIH HHS · DA07312 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com